Candid Therapeutics
About Candid Therapeutics
Candid Therapeutics develops targeted biologic therapies for autoimmune diseases by utilizing advanced immunomodulatory techniques to restore immune system balance. The company addresses the unmet need for effective treatments in a market where existing options often fail to provide adequate relief for patients.
```xml <problem> Existing treatments for autoimmune diseases often fail to provide adequate relief, leaving a significant unmet need for effective therapies that can restore immune system balance. Current options may have limited efficacy or undesirable side effects, highlighting the need for more targeted and innovative approaches. </problem> <solution> Candid Therapeutics develops targeted biologic therapies designed to address the root causes of autoimmune diseases by restoring immune system balance. The company utilizes advanced immunomodulatory techniques to create therapies that are more effective and have fewer side effects than existing treatments. By focusing on precision medicine, Candid Therapeutics aims to provide personalized treatment options that can significantly improve patient outcomes and quality of life. Their approach seeks to modulate the immune system in a way that promotes long-term remission and reduces the need for chronic immunosuppression. </solution> <features> - Development of targeted biologic therapies for autoimmune diseases - Utilization of advanced immunomodulatory techniques - Focus on restoring immune system balance - Personalized treatment options for improved patient outcomes </features> <target_audience> The primary target audience includes individuals suffering from autoimmune diseases and the healthcare providers who treat them, such as rheumatologists, immunologists, and other specialists. </target_audience> ```
What does Candid Therapeutics do?
Candid Therapeutics develops targeted biologic therapies for autoimmune diseases by utilizing advanced immunomodulatory techniques to restore immune system balance. The company addresses the unmet need for effective treatments in a market where existing options often fail to provide adequate relief for patients.
Where is Candid Therapeutics located?
Candid Therapeutics is based in San Diego, United States.
When was Candid Therapeutics founded?
Candid Therapeutics was founded in 2024.
How much funding has Candid Therapeutics raised?
Candid Therapeutics has raised 370000000.
Who founded Candid Therapeutics?
Candid Therapeutics was founded by Ken Song.
- Ken Song - CEO
- Location
- San Diego, United States
- Founded
- 2024
- Funding
- 370000000
- Employees
- 32 employees
- Major Investors
- TCG Crossover, Venrock Healthcare Capital Partners